FLUTICASONE
Formspray
Half of the 400 mcg mono-dose nasal drop container instilled into each nostril once or twice daily. - As directed; reassess and consider ENT referral if polyps or obstruction persist.
Labelled for adults, the elderly, and children over 16 years for this nasal-drop formulation; nasal polyps in a younger child are rare and warrant ENT referral rather than routine treatment (consider cystic fibrosis).
Egyptian National Drug Formulary - respiratory-2026.pdf, Fluticasone monograph (chapter PDF p77)
The formulary specifically indicates fluticasone mono-dose nasal drops for management of nasal polyps and related obstruction, making it the direct first-choice treatment.
- Given as a nasal drop, not swallowed: the dose is a 400 mcg mono-dose drop instilled into each nostril.
- A unilateral polyp, especially with bleeding, needs ENT referral to exclude a tumour rather than being treated as routine polyposis.
- Polyps in a child are rare and warrant work-up for cystic fibrosis.
- Local irritation, dryness, or epistaxis can occur.
- Refer to ENT if polyps are large or symptoms persist despite treatment.
| Egyptian brand | Manufacturer | Indicative price |
|---|---|---|
| RHINORELIEF NASAL SUSP. 50 MCG/METERED SPRAY DOSE | ARAB DRUG COMPANY (ADCO) | 32.00 EGP |
| TICANASE 0.05% NASAL SPRAY 12 GM | EUROPEAN EGYPTIAN PHARM. IND. | 70.00 EGP |
| FLIX NASAL SPRAY 50 MCG/METERED SPRAY DOSE | EVA PHARMA | 76.00 EGP |
| FLOHALE HFA 250MCG/DOSE AEROSOL 120 DOSES | CIPLA LTD. - INDIA > STAR INTERNATIONAL COMPANY | 95.00 EGP |
| FLIXONASE 50 MCG/METERED NASAL SPRAY 120 DOSE | GLAXO SMITHKLINE | 133.00 EGP |